| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |